Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Stoke Therapeutics Inc buy TD Cowen

Start price
€9.30
26.03.24 / 50%
Target price
-
26.03.25
Performance (%)
-27.42%
End price
€6.75
27.03.25
Summary
This prediction ended on 27.03.25 with a price of €6.75. The prediction for Stoke Therapeutics Inc disappointed with a performance of -27.42%. TD_Cowen has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Stoke Therapeutics Inc 9.774% 9.774% 135.484%
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

Comments by TD_Cowen for this prediction

In the thread Stoke Therapeutics Inc diskutieren

Stoke Therapeutics, Inc. (NASDAQ: STOK) was upgraded by analysts at TD Cowen from a "market perform" rating to an "outperform" rating.
Ratings data for STOK provided by MarketBeat

In the thread Trading Stoke Therapeutics Inc
Prediction Buy
Perf. (%) -27.42%
Target price
Change
Ends at 26.03.25

Die von TD_Cowen gewählte maximale Laufzeit wurde überschritten